Real-world Outcomes of Peripheral T-cell Lymphoma: A Multicenter Retrospective and Prospective Cohort Study

Abroad (travel likely)Recruiting

Conditions

Peripheral T-Cell Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Rong Tao, MD) · hkutao@hotmail.com · 021-64175590
Contact: Study coordinator (Chuanxu Liu, MD) · liuchaunxu@shca.or.cn · 021-64175590
Contact: Principal Investigator (Chuanxu Liu, MD)

Study leads

Rong Tao, MD
Study Chair
Fudan University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

Peripheral T-cell Lymphomas · Lymphoproliferative Disorders · Immune System Diseases

Abroad (travel likely)RecruitingPHASE2

Bethesda, United States · Minneapolis, United States

A Phase I Trial Anti-CC Chemokine Receptor 4 Chimeric Antigen Receptor T Cells (CCR4 CAR T Cells) for CCR4 Expressing T-cell Malignancies Including Peripheral T-cell Non-Hodgkin Lymphoma (PTCL) and Cutaneous T-cell Non-Hodgkin Lymphoma (CTCL)

Relapsed and/or Refractory Mature T Cell Malignancy · Peripheral T-Cell Lymphoma · Angioimmunoblastic T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE1

Bethesda, United States

Chidamide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Relapsed or Refractory Peripheral T-cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

Kaohsiung City, Taiwan · Kaohsiung City, Taiwan

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

T-Cell Lymphoma

Abroad (travel likely)RecruitingPHASE2

New Haven, United States · Boston, United States